 |
|
The Course of Retinopathy in Treated Malignant Hypertension
G. LOCKHART, M.D.;
G. von NOORDEN, M.D.;
HARRIET P. DUSTAN, M.D.;
A. C. CORCORAN, M.D.;
IRVINE H. PAGE, M.D.
Arch Intern Med. 1960;106(2):205-212.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The concurrent development of papilledema, retinal hemorrhages, and exudates in the course of hypertensive disease is regarded as a cardinal sign of necrotizing arteriolar disease (accelerated or malignant hypertension). Hence, these retinal signs have serious prognostic significance.1 In recent years, effective antihypertensive treatment has improved the immediate prognosis of malignant hypertension; with adequate blood-pressure control, papilledema, retinal hemorrhages, and exudates disappear and extraretinal signs of progressive hypertensive vascular disease remit.
The purpose of this report is to review the retinal abnormalities of patients with malignant hypertension with regard to their prognostic significance; to describe the effect of antipressor therapy on these abnormalities, and to show the association of the retinal changes with the effects of treatment on the extraretinal manifestations of the disease.
Methods and Material
Patients Studied.
—The group was composed of 96 patients with apparent "primary" or "essential" hypertension in the malignant phase; all but one had
. . . [Full Text PDF of this Article]
Author Affiliations
Canton, Ohio; Iowa City; Cleveland
From the Department of Ophthalmology and the Research Division of the Cleveland Clinic Foundation and the Frank E. Bunts Educational Institute.
Footnotes
Submitted for publication Nov. 25, 1959.
Present address: 800 McKinley Street, Canton, Ohio (Dr. Lockhart); present address: University Hospital, Iowa City (Dr. von Noorden); present address: St. Vincents Charity Hospital, Cleveland (Dr. Corcoran).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
